Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
about
Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effectDNA Tumor Viruses and Cell MetabolismKeeping it quiet: chromatin control of gammaherpesvirus latencyRoles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implicationsDifferent Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma CellsExosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells.The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphomaHuman viruses and cancer.Epstein-Barr virus genetic variants are associated with multiple sclerosis.Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.Interaction of human tumor viruses with host cell surface receptors and cell entryScreening and functional analysis of differentially expressed genes in EBV-transformed lymphoblastsSorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Cell type-specific properties and environment shape tissue specificity of cancer genes.Immune surveillance and lymphoid malignancy in immunocompromised host.Limited but durable changes to cellular gene expression in a model of latent adenovirus infection are reflected in childhood leukemic cell lines.Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.Kaposi's Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis.Condylomatous genital lesions in cynomolgus macaques from Mauritius.HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.Emerging topics in human tumor virology.Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.Epstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology.The labyrinth of interactions of Epstein-Barr virus-encoded small RNAs.Noise in multiple sclerosis: unwanted and necessary.Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin.Healthy rabbits are susceptible to Epstein-Barr virus infection and infected cells proliferate in immunosuppressed animals.Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.Peptide matching between Epstein-Barr virus and human proteins.Specific tumor-stroma interactions of EBV-positive Burkitt's lymphoma cells in the chick chorioallantoic membrane.The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes.Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program.
P2860
Q24294513-4B1E2B20-E4DA-4E50-BD67-DD4DCFF76FB5Q26749066-D4B3CA9F-F06B-4C2A-A58B-4593F67FAFEBQ26865827-CBB0BC50-FBB6-4FA3-9662-7D269DFAA58DQ27009016-06B74C10-2A4E-43F3-B855-D62B43EC0BD1Q28547526-6031ED33-F329-4FE6-A050-D71D5505B8F9Q30587658-2F906A47-78A8-4748-8289-B02B92920128Q34028372-58D3DF48-394E-42E3-BF3D-6DF589F72091Q34423461-ADAC9D98-CE22-4956-91B3-CC46E9BF06B6Q34465744-3E7BD803-12B3-4950-8A4F-1797E6D9551AQ34557179-AC78B9EE-6281-4D55-95A4-66154C22CD21Q35676027-0BD205B9-7542-4574-A16A-6D33704D283AQ36207171-851A6DB8-956E-4F18-9E29-B992FD5AB8C2Q36301590-FCCB5F4D-97EB-438E-906B-3A5026DF5E01Q36399124-281D661B-9311-451F-9072-ED8113C6EF93Q36559901-86CC0F1F-D357-4E64-8DD1-5B4A26B0650AQ36831205-2FEC7E8B-27BE-4343-806C-D0498FECEB8AQ37097260-2F2467D7-57B1-413A-BDE8-B6A072350C62Q37484088-598BAABE-7AB7-4B2A-B817-C22A32D4C732Q37632632-1B3092A2-DCFC-4008-8545-BB5D2C802F14Q37693289-27F9420D-D542-44A8-912F-17C181875FE8Q37780706-72FEFC0B-649E-4AC8-9A43-C583E3357817Q37849461-7A728836-0D08-41F5-A163-2884EF7F162CQ37858935-630139CF-BB0F-45A8-92F9-CBD922309B1BQ38086861-A1E57A12-9041-4B4B-A9F0-5D86F11C6447Q38101668-283A4544-6637-48D4-B553-6495202F8DE7Q38150803-6AF777D9-D98C-465F-A565-894064506139Q38263875-FB858803-8FD6-43BE-BBCB-CA824A9E561DQ38819714-CB808E57-2D94-4B4E-BD82-ED1F06D6B2CBQ40750161-360DEAEA-1A90-4527-B4CE-54C446D5400FQ41108399-08BAAEE4-3CA0-490E-B266-C881A89ACED5Q41656686-02E7502D-CAAD-41DA-AFDE-A99DD1FD0DDCQ41902982-B47746E1-53E1-429F-8FD3-31CF481E38AFQ42229225-2E41602C-1E6F-4839-99C9-7C825179158BQ42261208-E4A77020-1145-4CDB-8A2E-02CB0547B27CQ42282416-9582974E-D17C-47EC-AFA3-192725F12308Q42547317-FC192E50-CCFB-4575-84BA-A135214B080BQ45840997-7D4A0B57-C9CA-461A-B357-C71B3D95621FQ47102132-11A10932-691D-4222-90C0-CF77866723EBQ53239923-53828EAA-D740-4DA2-BC3B-A396F3114146Q55263694-2FBB4521-6666-4A95-B946-4F67F8ECAA38
P2860
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
@en
Interaction of Epstein-Barr virus
@nl
type
label
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
@en
Interaction of Epstein-Barr virus
@nl
prefLabel
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
@en
Interaction of Epstein-Barr virus
@nl
P1476
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
@en
P2093
George Klein
P356
10.1016/J.BBRC.2010.02.146
P407
P577
2010-05-01T00:00:00Z